Rosetta Genomics (Nasdaq: ROSG), reports that data from a study validating the Company's miRview lung assay was published in the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE